XML 26 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
¥ in Millions, $ in Millions
CNY (¥)
shares
USD ($)
shares
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
CNY (¥)
Ordinary shares
CNY (¥)
shares
Additional paid-in capital
CNY (¥)
Statutory reserves
CNY (¥)
Accumulated other comprehensive income/(loss)
CNY (¥)
Retained earnings
CNY (¥)
Retained earnings
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
CNY (¥)
Treasury stock
CNY (¥)
shares
Total Ctrip's shareholders' equity
CNY (¥)
Total Ctrip's shareholders' equity
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
CNY (¥)
Non-controlling interests
CNY (¥)
Changes in shareholders' equity                          
Issuance of ordinary shares for the exercise of stock options (in shares) | shares 3,495,960 3,495,960   6,935,904 [1]                  
Balance at Dec. 31, 2019 ¥ 105,703   ¥ (83) ¥ 6 ¥ 83,614 ¥ 635 ¥ (1,505) ¥ 22,803 ¥ (83) ¥ (2,111) ¥ 103,442 ¥ (83) ¥ 2,261
Balance (in shares) at Dec. 31, 2019 | shares [1]       592,691,232           (23,432,968)      
Changes in shareholders' equity                          
Issuance of ordinary shares for the exercise of stock options 159       159           159    
Share-based compensation 1,873       1,873           1,873    
Appropriations to statutory reserves           3   (3)          
Foreign currency translation adjustments 75           75       75    
Unrealized securities holding losses (178)           (178)       (178)    
Accretion of redeemable non-controlling interests (40)             (40)     (40)    
Net income / (loss) (3,269)             (3,207)     (3,207)   (62)
Deconsolidation of shares in subsidiaries 176                       176
Issuance of additional equity stake by subsidiaries 5                       5
Disposal of shares in subsidiaries (234)       0 (1)         (1)   (233)
Equity transaction in which a non-controlling interest in a subsidiary is exchanged for a non-controlling interest in another subsidiary         9           9   (9)
Acquisition of additional shares in subsidiaries (2,620)       (1,695)           (1,695)   (925)
Balance at Dec. 31, 2020 ¥ 101,567     ¥ 6 83,960 637 (1,608) 19,470   ¥ (2,111) 100,354   1,213
Balance (in shares) at Dec. 31, 2020 | shares [1]       599,627,136           (23,432,968)      
Changes in shareholders' equity                          
Issuance of ordinary shares for the exercise of stock options (in shares) | shares 5,106,035 5,106,035   5,321,521 [1]                  
Issuance of ordinary shares for the exercise of stock options ¥ 307     ¥ 0 307           307    
Share-based compensation 1,681       1,681           1,681    
Appropriations to statutory reserves           97   (97)          
Foreign currency translation adjustments 2           2       2    
Unrealized securities holding losses 2           2       2    
Accretion of redeemable non-controlling interests 0                        
Net income / (loss) (645)             (550)     (550)   (95)
Issuance of ordinary shares, net of issuance costs 7,984     ¥ 0 7,984           7,984   0
Issuance of ordinary shares, net of issuance costs (shares) | shares [1]       36,380,900                  
Acquisition of additional shares in subsidiaries (442)       (103)           (103)   (339)
Business combination 0                       0
Establishment of subsidiaries 0                       0
Balance at Dec. 31, 2021 ¥ 110,456     ¥ 6 93,829 734 (1,604) 18,823   ¥ (2,111) 109,677   779
Balance (in shares) at Dec. 31, 2021 | shares [1]       641,329,557           (23,432,968)      
Changes in shareholders' equity                          
Issuance of ordinary shares for the exercise of stock options (in shares) | shares 4,493,648 4,493,648   4,737,273                  
Issuance of ordinary shares for the exercise of stock options ¥ 179     ¥ 0 179           179    
Share-based compensation 1,188       1,188           1,188    
Appropriations to statutory reserves           91   (91)          
Foreign currency translation adjustments 78 $ 11         78       78    
Unrealized securities holding losses (1,126)           (1,126)       (1,126)    
Accretion of redeemable non-controlling interests 0 0                      
Less: Amounts reclassified from accumulated other comprehensive income/(loss) to net (loss)/income (Note 7) 884           884       884    
Net income / (loss) 1,367             1,403     1,403   (36)
Disposal of shares in subsidiaries (4)                       (4)
Acquisition of additional shares in subsidiaries (3)       0           0   (3)
Balance at Dec. 31, 2022 ¥ 113,019 $ 16,386   ¥ 6 ¥ 95,196 ¥ 825 ¥ (1,768) ¥ 20,135   ¥ (2,111) ¥ 112,283   ¥ 736
Balance (in shares) at Dec. 31, 2022 | shares       646,066,830           (23,432,968)      
[1] The number of shares outstanding and treasury stock have been retrospectively adjusted for the Share Subdivision that became effective on March 18, 2021 as detailed in Note 2 and Note 20.